OR WAIT null SECS
December 31, 2020
Administration of the COVID-19 vaccination from Oxford University and AstraZeneca is expected to begin in the UK in early 2021.
December 21, 2020
A decision by the European Commission on conditional marketing authorization for the European Union’s first COVID-19 vaccine is expected soon.
December 11, 2020
The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have published a joint strategy for medicines regulation in Europe over the next five years.
December 03, 2020
Industry should improve the standards on application of risk management tools in light of the cases of nitrosamine impurities.
December 02, 2020
The success of virtual GMP inspections performed during the pandemic may lead to more flexible opportunities in the future.
November 24, 2020
HMA and EMA have released a joint statement on the appropriate route for companies to submit marketing authorization applications and the approval processes for vaccines.
November 18, 2020
The agency’s safety monitoring plan outlines how information that emerges after the authorization of COVID-19 vaccines will be collected and reviewed.
The guidance was published in connection with a safety monitoring plan for COVID-19 vaccines.
The agency marked the annual European Antibiotic Awareness Day with the launch of a social media campaign highlighting the prudent use of antibiotics.
November 04, 2020
Experts examine the role technology can play in quality programs at the 2020 Bio/Pharma Virtual Congress.